Search for Clinical Trial Results

Sponsored By

Encephalomyopathy - 25 Studies Found

Status Study
Recruiting Study Name: MNGIE Allogeneic Hematopoietic Stem Cell Transplant Safety Study
Condition: Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE)
Date: 2015-02-10
Interventions: Biological: Hematopoietic Allogeneic Stem Cells HLA 10/10 matched allogeneic bone marrow cells will be i
Recruiting Study Name: Natural History Study - Mitochondrial Disease
Condition: MELAS or m.3243 A>G Mitochondrial DNA Mutation Carrier
Date: 2012-02-10
Recruiting Study Name: The KHENERGY Study
Condition:
  • Mitochondrial Diseases
  • Mitochondrial Myopathies
  • Mitochondr
    Date: 2016-09-13
    Interventions:
    • Drug: KH176
    • Drug: placebo
Recruiting Study Name: The Leigh Syndrome Registry
Condition:
  • Leigh Syndrome
  • Leigh Disease
  • Leigh's Necrotizing Encephalo
    Date: 2017-04-28
Completed Study Name: Study of Idebenone in the Treatment of Mitochondrial Encephalopathy Lactic Acidosis & Stroke-like Episodes
Condition: MELAS Syndrome
Date: 2009-04-23
Interventions:
  • Drug: Idebenone 900 mg/day for
Recruiting Study Name: MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis
Condition:
  • Mucopolysaccharidosis Disorders
  • Hurler Syndrome
  • Hunter Syn
    Date: 2014-06-20
    Interventions:
    • Biological: Stem Cell Transplantation

Not yet recruiting Study Name: Safety, Tolerability and Pharmacokinetic Study of KL1333 in Healthy Male Volunteers
Condition:
  • MELAS Syndrome
  • Mitochondrial Respiratory Chain Deficiencies

Date: 2017-02-05
Interventions:
  • Drug: KL1333 25 mg oral admini
Completed Study Name: Responses to Influenza Vaccine in Patients With Mitochondrial Disorders (MELAS)
Condition: MELAS Syndrome
Date: 2013-03-19
Interventions: Biological: Fluzone® This vaccine is given intramuscularly, either the 2010-2011 or 2011-2012 vacci
Completed Study Name: Ketones & Mitochondrial Heteroplasmy
Condition:
  • MELAS Syndrome
  • Mitochondrial Diseases

Date: 2010-12-01
Interventions: Dietary Supplement: Medium-Chain Triglycerides Subjects will take supplemental MCT oil 3 times a day for
Completed Study Name: L-arginine Therapy on Endothelium-dependent Vasodilation & Mitochondrial Metabolism in MELAS Syndrome
Condition: MELAS Syndrome
Date: 2012-05-18
Interventions: Drug: L-Arginine NOW® L-Arginine powder
Next >>>